Jianzhuo Medical Materials Files IPO Prospectus: Advancing Customized and Localized Medical Polymer Solutions to Break Foreign Monopoly
Medical polymer materials are among the fastest-growing materials in the emerging materials industry.Due to the superior properties of medical-grade polymer materials and their ability to reduce costs, polymers have become indispensable in the production of medical supplies and devices, ranging from large-scale diagnostic equipment and disposable medical products to sophisticated artificial organs. Consequently, polymer materials are increasingly becoming one of the key raw materials for medical supplies and devices.
According to statistics, there are more than 90 varieties and over 1,800 types of products of medical polymer materials already in use worldwide. The global production and sales volume of medical polymer materials was approximately 4.391 million tons in 2011, reaching about 6.771 million tons in 2019.From 2011 to 2019, the global production and sales volume of medical polymer materials grew at a compound annual growth rate (CAGR) of 5.6%.
Currently, the development and application of medical polymer materials abroad are very active. According to statistics from Transparency Market Research, in 2013, the global market size of the medical polymer materials industry was $9.8 billion,In 2019, the global market size of the medical polymer materials industry reached $17.13 billion,From 2013 to 2019, the global market size of the medical polymer materials industry achieved a compound annual growth rate (CAGR) of 8.3%.
Jianzhuo Medical Materials specializes in the research, development, and production of medical-grade polymer materials. Founded by two middle school classmates, the company is committed to becoming an industry benchmark for medical polymer materials in China.The company has obtained ISO 13485 certification for its medical device quality management system, and its products have passed ISO 10993 biocompatibility testing., simultaneously collaborating with over 30 renowned medical and biotechnology enterprises, and carry out research and development of new projects.
Medical polymer materials, in a broad sense, refer to all polymeric materials used in medical activities. In a narrow sense, they refer to functional polymeric materials designed for medical purposes, applied to the human body, possessing specialized properties, and meeting specific medical requirements. Medical polymer materials consist of a polymer matrix and additives. Based on the properties of the synthetic materials, synthetic medical polymers can be classified into biodegradable and non-biodegradable synthetic medical polymer materials.
In terms of the proportion of application endpoints, medical polymer materials are primarily used in the production of medical devices such as medical consumables and implants, with only a very small fraction of high-end medical polymer materials being utilized as drug-controlled release carriers.
From the perspective of medical device classification, medical-grade polymer materials such as polyvinyl chloride (PVC) and polycarbonate are widely used in the manufacturing of Class I and Class II medical devices, including low-value medical consumables like disposable infusion sets, blood transfusion sets, and indwelling needles. In contrast, medical-grade polymers with more prominent performance advantages, such as polypropylene and polyethylene, are more frequently applied in Class III medical devices.
According to statistics from Grand View Research, medical devices and instruments currently account for the largest share of global demand for medical polymer products, at 55%, followed by medical packaging at 35%.
As one of the eight key high-tech sectors prioritized for national support, polymer materials have received substantial backing from the Chinese government for related technological innovation, material research, and applications. Consequently, medical-grade polymer materials have benefited significantly from this policy support, leading to continuous improvements in industry R&D capabilities, a steady pipeline of specialized talent, and robust growth in the sector.
Dr. Yu Haiou, who is deeply engaged in the research and development of medical polymer materials, is deeply aware that ChinaDomestic medical consumables and medical equipment enterprises face the pain points of long production cycles, high costs, and difficulties in innovation due to the monopoly of foreign materials.In 2018, Jianzhuo Medical Materials was officially established, dedicated to addressing the challenges facing the industry's development.
Zhang Jie, one of the founders of Jianzhuo Medical Materials, holds a Master’s degree in Engineering Management and has 12 years of experience in managing multinational Fortune 500 companies. He possesses extensive expertise in market management, project management, import-export trade, and supply chain management.
Another co-founder, Yu Haiou, holds a Ph.D. in Polymer Materials from the Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, completed postdoctoral research at South China University of Technology, and served as a research scholar at the College of Engineering, University of Colorado Boulder (USA). He has been specializing in the field of medical polymer materials for over 15 years.He previously served as the R&D Director for two publicly listed companies in China.Such experience enables him to address technical challenges in the research and development of medical products from perspectives distinct from those of biology majors.Starting from the molecular structure of materials to meet diverse application scenarios of various medical polymer materials, satisfy high-quality demands, and address issues related to the performance, quality, regulations, and medical standards of polymer materials.
This has also formed the core advantages of Jianzhuo Medical Materials, namely high efficiency, precise R&D, customized production, and cost optimization.
High efficiency is achieved by Jianzhuo Medical Materials through independently developed materials that eliminate the complex procedures and production transportation time associated with imported materials, thereby significantly shortening product delivery timelines. By engaging in direct dialogue with customers and responding rapidly to their needs, Jianzhuo Medical Materials leverages a standardized quality management system to meet clients’ precise R&D requirements and customized mass-production demands.
Cost Optimization: Building on the aforementioned advantages, Jianzhuo Medical Materials’ independently developed products have significantly reduced the procurement and production costs of medical polymer materials.
In addition,More importantly, Jianzhuo Medical Materials can help customers establish control standards for materials and quality inspection., resolve long-term usage issues, extend product service life, and truly ensure that the product meets its promised lifespan.
Regarding future R&D plans, Dr. Yu Haiou stated that a three-step strategy would be adopted: first, developing hydrophilic and hydrophobic materials for products that come into contact with blood and drugs; second, conducting R&D on functional devices and materials that enhance performance and management efficiency, including semi-finished membrane products; and third, advancing the R&D of implantable materials.
Based on an in-depth understanding of the healthcare industry, and in light of product application pain points and regulatory requirements,Jianzhuo Medical Materials has selected medical-grade raw materials to develop a series of functional products, with R&D tailored to local conditions. Its primary manufacturing capabilities focus on medical plastics and medical thermoplastic elastomers.Jianzhuo's medical material products can be widely applied in in vitro diagnostics (IVD), medical consumables, and medical devices.
In vitro diagnostics (IVD) materials, primarily for molecular diagnostics, exhibit low DNA adsorption and do not interfere with PCR reactions. They meet diverse sterilization requirements, including steam autoclaving, irradiation, and ethylene oxide sterilization, while demonstrating excellent biocompatibility and high purity, in compliance with ISO 10993 certification.Key product applications include the PCR series, pipettes, and tips.This application accounts for 50% of Jianzhuo's medical materials.
For medical consumables, tailored to the specific characteristics of these products, the materials offer functionalities such as radiation resistance, chemical resistance, drug resistance, high strength, high toughness, high transparency, overmolding capability, and resistance to extreme temperatures.Major product applications include orthodontic aligners, health wearables, trocars, infusion filters, indwelling needles, and medical catheters.Applications in this field account for 30% of Jianzhuo’s medical materials.
For medical devices, Jianzhuo Medical Materials has selected medical-grade raw materials to develop a series of functional products tailored to product applications, pain points, and regulatory requirements. These products offer features such as chemical resistance, colorability, high transparency, biocompatibility, self-lubrication, sound insulation and noise reduction, and UVC aging resistance.Main product applications include anesthesia machines and ventilators.This application area accounts for 20% of Jianzhuo's medical materials.
In 2021, Jianzhuo Medical Materials won the First Prize in the “Puchuang 108” Competition organized by the Shanghai Municipal Commission of Economy and Informatization, as well as the First Prize in the Shanghai Fengxian Oriental Beauty Valley Big Health Industry Competition. Additionally, it was the only domestic medical polymer materials company invited to deliver a speech at the MEDTEC China International Medical Device Design and Technology Exhibition.
When discussing the development of Jianzhuo Medical Materials, Zhang Jie proposed future strategic directions from three aspects.
On the one hand,Corporate investment priorities are primarily focused on building technological capabilities and brand equity., a strong brand helps enhance the market price and competitiveness of Jianzhuo medical materials; on the other hand, the medical polymer industry is an emerging sector characterized by high technological content and extensive multidisciplinary integration and cross-pollination,High-caliber talent with interdisciplinary expertise and R&D application capabilities is a core resource., technological R&D can enhance a company’s operational efficiency and product performance, thereby boosting the industry’s overall competitiveness and increasing the value-added of customers’ products.
Finally, regarding its long-term corporate development plan, Jianzhuo Medical Materials stated that,Seeking Strategic Partnerships with Professional Healthcare Investment Firms, with the company’s future goal being to achieve a public listing; in terms of R&D collaboration, the area with the greatest potential for mutual benefit lies in engaging customers in early-stage research and experimentation, thereby delivering materials with higher technological sophistication and competitiveness, while simultaneously designing new intellectual property and patent protection strategies.